Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. (Q45203862)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 November 2012

Language	Label	Description	Also known as
English	Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.	scientific article published on 21 November 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hepatitis B virus

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Yi-Hsuan Hsieh

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ih-Jen Su

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Chia-Jui Yen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ting-Fen Tsai

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hung-Wen Tsai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Han-Ni Tsai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yu-Jun Huang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yen-Yu Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yu-Lin Ai

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Lin-Yuan Kao

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Wen-Chuan Hsieh

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Wenya Huang

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

0 references

publication date

21 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

475-485

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Viral hepatocarcinogenesis: from infection to cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Clinical development of histone deacetylase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Thioredoxin and thioredoxin binding protein 2 in the liver

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Posttranslational regulation of NF-YA modulates NF-Y transcriptional activity.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45203862&oldid=1287821916"